Bridge Research Consortium

@bridgerc.bsky.social

526 Followers 1525 Following

Bringing together a multidisciplinary team of leading #SocialSciences and #Humanities scholars from across Canada to better understand and support #PublicTrust and equitable access to new #vaccines and immune-based innovations. #PublicHealth

Full-time, 37 hours per week $70,000 to $85,000 CAD per year plus benefits Depending on current project: SFU or UBC campus or remote The Knowledge Mobilization Specialist conducts the planning, implementation and evaluation of activities within the Bridge Research Consortium (BRC), Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH), and other collaborating hubs. The Specialist will contribute to boosting KMb capacity within the BRC and will have the opportunity to lead the development of outputs, products, activities, and events to advance public trust and equitable access to new vaccines and immune-based innovations related to pandemic preparedness and response. This role will work under the direction of the KMb Lead. ABOUT THE BRIDGE RESEARCH CONSORTIUM The BRC is one of four projects funded by the Government of Canada, as part of Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH) led by the University of British Columbia. It is also one of 19 projects funded in 2024, under Canada’s Biomanufacturing and Life Sciences Strategy, “to rebuild a strong and resilient domestic biomanufacturing and life sciences sector” ahead of a future pandemic event. While Canada is poised to achieve exciting and important scientific breakthroughs, the COVID-19 pandemic showed that support for the optimal uptake of new vaccines and therapies is also needed. The decline of vaccine uptake within some populations over the past decade risks the return of vaccine preventable diseases and undermines the capacity for Canada to respond effectively to a future pandemic. In this context, the BRC has been funded as a unique collaboration of leading social sciences and humanities scholars across Canada. The Consortium brings together expertise in anthropology, bioethics, communications, history, international relations, law, political science, public administration, sociology and other disciplines, with public health, clinical medicine, and nursing.
Full-time, 37 hours per week $60,000 to $75,000 CAD per year plus benefits Simon Fraser University Burnaby Campus (hybrid negotiable) The Training Specialist will lead the planning, implementation, and evaluation of training and pedagogical activities and the development of tools and resources to build knowledge mobilization, science, communication, professional development, and equity capacity within the Bridge Research Consortium (BRC), CIEBH and other hubs. This role will work under the direction of the KMb Lead. ABOUT THE BRIDGE RESEARCH CONSORTIUM The BRC is one of four projects funded by the Government of Canada, as part of Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH) led by the University of British Columbia. It is also one of 19 projects funded in 2024, under Canada’s Biomanufacturing and Life Sciences Strategy, “to rebuild a strong and resilient domestic biomanufacturing and life sciences sector” ahead of a future pandemic event. While Canada is poised to achieve exciting and important scientific breakthroughs, the COVID-19 pandemic showed that support for the optimal uptake of new vaccines and therapies is also needed. The decline of vaccine uptake within some populations over the past decade risks the return of vaccine preventable diseases and undermines the capacity for Canada to respond effectively to a future pandemic. In this context, the BRC has been funded as a unique collaboration of leading social sciences and humanities scholars across Canada. The Consortium brings together expertise in anthropology, bioethics, communications, history, international rel ations, law, political science, public administration, sociology and other disciplines, with public health, clinical medicine, and nursing. The project brings together wide-ranging perspectives to better understand and support public trust and equitable access to new vaccines and immune-based innovations that strengthen Canada’s readiness for future health emergencies.